Silo Pharma (SILO) Stock Price
Silo Pharma Price
Revenue at Silo Pharma has contracted by 3.1% per year over the past 12 years to 72,102.00 USD. Earnings per share have grown at 58.6% per year over the last 8 years. For Silo Pharma, the net margin of -5,863.5% is down versus 5,477.9% a few years ago.
Silo Pharma stock price
Silo Pharma business model & stock analysis
Frequently asked questions about Silo Pharma
7 analysts currently rate the Silo Pharma stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Silo Pharma to generate revenue of 73,440.00 USD and earnings per share of -11.02 USD.
Converted at the current exchange rate, the Silo Pharma share trades at 1.25 EUR (1.40 USD).
The expected revenue of Silo Pharma is 73,440.00 USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Silo Pharma is -9.78 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Silo Pharma is currently -0.13. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Silo Pharma stock.
The price-to-sales ratio (P/S) of Silo Pharma is currently 16.93. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Silo Pharma stock.
The Eulerpool Quality Score for Silo Pharma is 3/10.
The ISIN of Silo Pharma is US82711P2011. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Silo Pharma is SILO. The ticker symbol is used to trade Silo Pharma shares on the stock exchange.
Silo Pharma stock
Silo Pharma Peer Group
Silo Pharma FIGI
All fundamentals and in-depth analysis of Silo Pharma
Our stock analysis for Silo Pharma stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Silo Pharma. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.